Register for Upcoming Webinar on DEC. 8 @ 11AM
2026 China NMPA Bluebook is here:
Grace Palma, CEO of China Med Device On my flight to China, my seat mate is a Harvard Medical School professor specializing in stem cell research.
Grace Palma, CEO of China Med Device On my flight to China, my seat mate is a Harvard Medical School professor specializing in stem cell research.
Weekly CFDA News Roundup covers policies, regulations, QA/recall/AE, and new approvals in medical device and IVD in China. It is edited by China Med Device,
Monthly CFDA News Roundup covers policies, guidelines, QA/recall/AE, and new approvals in medical device and IVD in China. It is edited by China Med Device,
China National Cancer Center released the latest national report on the incidence and mortality rate of cancer on April 6. It is estimated that there
May 2, 2018 2-3 PM EST Registration is Closed China has become the 2nd largest med-tech market in the world. Chinese government plans to
Weekly CFDA News Roundup covers policies, regulations, QA/recall/AE, and new approvals in medical device and IVD in China. It is edited by China Med Device,
Severe cardiac arrhythmia is the leading cause of sudden cardiac death, and radiofrequency ablation is an important means of non-drug treatment of arrhythmia. During the
According to the statistics cited in the 2015 China Cardiovascular Diseases (CVD) report, the number of cardiovascular patients in China has reached 290 million. That
Esaote, Italian-based medical equipment company with a focus on ultrasound, magnetic resonance imaging and diagnostic management software, was acquired by consortium of fund from China
Shanghai CFDA office released Medical Device Quarterly Report on April 10. Total 63 medical devices have been voluntarily recalled in Shanghai for the first quarter
The public Chinese healthcare system is getting overcrowded. Medical resources are getting stretched thin. This is particularly evident in level III public hospitals. The government,